Phase 3 Resistant Hypertension Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Not Yet Recruiting
Phase 3
DORADO-AC – Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
Resistant Hypertension
Myogen, Inc.800 enrolled1 locationACTRN12606000446561
Recruiting
Phase 3
DORADO – Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
Resistant Hypertension
Myogen, inc.350 enrolled1 locationACTRN12606000292572